Koers MJardin Group, Inc. Canadian Securities Exchange
Aandelen
MJAR
CA60689X1096
Farmaceutische producten
Omzet 2019 | 26,7 mln. 36,57 mln. 24,99 mln. | Omzet 2020 | 11,44 mln. 15,66 mln. 10,7 mln. | Marktkapitalisatie | 3,41 mln. 4,67 mln. 3,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -267 mln. -366 mln. -250 mln. | Nettowinst (verlies) 2020 | -34 mln. -46,57 mln. -31,82 mln. | EV/omzet 2019 | 5,55 x |
Nettoschuld 2019 | 134 mln. 183 mln. 125 mln. | Nettoschuld 2020 | 164 mln. 224 mln. 153 mln. | EV/omzet 2020 | 14,6 x |
K/w-verhouding 2019 |
-0,06
x | K/w-verhouding 2020 |
-0,1
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 92,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 26-05-21 |
Edward Jonasson
DFI | Director of Finance/CFO | 55 | 01-11-19 |
Patrick Witcher
BRD | Director/Board Member | - | 07-05-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 26-05-21 |
Blair Jordan
BRD | Director/Board Member | 55 | 26-05-21 |
James Lowe
BRD | Director/Board Member | - | 06-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,54% | 6,12 mld. | |
-16,47% | 4,44 mld. | |
-10,16% | 3,14 mld. | |
-0,71% | 3,03 mld. | |
-1,06% | 2,57 mld. | |
+40,09% | 1,87 mld. | |
-0,76% | 1,63 mld. | |
-11,19% | 1,62 mld. | |
-12,74% | 1,53 mld. |